$85.00

CJC-1295 No DAC + Ipamorelin is a peptide combination studied in research for its potential effects on growth-hormone signaling and related physiological pathways. It is intended for laboratory and preclinical research only and is not approved as a medication for human therapeutic use.

Description

CJC-1295 No DAC + Ipamorelin — Product Description

CJC-1295 No DAC + Ipamorelin is a research peptide combination consisting of a growth hormone–releasing hormone (GHRH) analogue and a growth hormone secretagogue. The combination is commonly investigated in preclinical research concerning growth-hormone signaling and related physiological pathways.

Product Highlights

  • Compounds: CJC-1295 No DAC + Ipamorelin
  • Type: Synthetic peptide combination
  • Research focus: Growth hormone signaling, peptide pharmacology, and endocrine research
  • Form: Typically supplied as lyophilized powder
  • Purity: Specify your verified analytical purity
  • Intended use: Laboratory and scientific research
  • Storage: Follow validated manufacturer storage conditions

Suggested Product Copy

CJC-1295 No DAC + Ipamorelin Research Peptide
A research-grade peptide combination featuring CJC-1295 No DAC and Ipamorelin, designed for laboratory investigations into growth hormone–related signaling pathways and peptide pharmacology. The combination provides researchers with a convenient format for studying the interaction of two distinct peptide secretagogues in controlled research settings.

Supplied as a lyophilized research compound for qualified laboratory use. Not intended for human or veterinary use, diagnosis, treatment, or prevention of disease.

Reviews

There are no reviews yet.

Be the first to review “CJC No DAC + Ipamorelin”

Your email address will not be published. Required fields are marked *